… review, immunotherapy is an efficient therapeutic option intervention against COVID-19 and the … and plasma therapy have improved clinical outcomes in COVID-19 infected patients. …
… administration, passive immunotherapy by convalescent … immunotherapeutic approaches that will be mentioned in this review. The focus would be on passive immunotherapeutic …
… strategies that are supported in expert guidelines, such as anti-IL-6R blockade and corticosteroids; however, we will augment this guidance with possible treatment options for when …
… Passive immunotherapy has been used as a reliable treatment option for many infectious … , and immunogenicity of passive immunotherapy for the treatment of COVID-19. As of now on 9 …
A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
… clinical data on the immunopathogenesis of the COVID‐19 and review the innate and adaptive … immunotherapies as well as reviewing recruiting/completed clinical trials of COVID‐19. …
… Most of the therapeutic options that are available for managing COVID-19 are based … COVID-19. Citation16 The major therapeutic drugs that might be effective in managing COVID-19 …
… treatments as a kind of passive immunotherapy may be appropriate to achieve COVID-19 treatment [66]. In this section, immunotherapy based on the antibody include neutralizing …
C Korsukewitz, SW Reddel, A Bar-Or… - Nature reviews …, 2020 - nature.com
… option) during the COVID-19 pandemic, and the first reports of SARS-CoV-2 infection in patients receiving natalizumab therapy have suggested no increase in risk 67,68 . Furthermore, …
… characterize the early immune response to COVID-19 that causes severe lung damage and … immunotherapies as an adjunct therapy in severe COVID-19 cases. Such immunotherapies …